B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

Amprenavir

0 PubMed studies analyzed

Similar Compounds by Shared Targets

The following compounds share molecular targets with Amprenavir, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

lacidipine
2 shared targets
indinavir
2 shared targets
benzylimidazole
2 shared targets
candesartan
2 shared targets
ergocornine
2 shared targets
closantel
2 shared targets
nelfinavir
2 shared targets
oxiconazole
2 shared targets
nifedipine
2 shared targets
sulconazole
2 shared targets
Loading evidence profile...

This evidence profile for Amprenavir is generated deterministically from 0 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: v20260227-01. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.